Filter by

of 1 Next >
Results Found: 1
  • NYU Dataset

    Augmentation of Parasympathetic Signaling with Pyridostigmine in Heart Failure

    Alternate Title(s)
    APP-HF
    Authors
    Randal Goldberg
    Lucy Norcliffe-Kauffman
    Ikoa Jeschke-Lopez
    Yu Guo
    8 more author(s)...
    Description

    This dataset was collected during a prospective phase 2 double-blind randomized placebo-controlled a dose-finding clinical trial to compare the effects of three ascending doses of pyridostigmine (15, 30, and 60 mg three times daily) vs. matching placebo on post-exercise heart rate recovery and other measures of sympathovagal balance. The study included four stages: Screening, randomization, and baseline...

    Subject
    Chronic Disease
    Health Status
    Risk Factors
    Access Rights
    Application Required
    Author Approval Required